Skip to main content
Yantai Zhenghai Bio-Tech Co., Ltd. logo

Yantai Zhenghai Bio-Tech Co., Ltd. — Investor Relations & Filings

Ticker · 300653 ISIN · CNE100002NZ1 Shenzhen Stock Exchange Manufacturing
Filings indexed 968 across all filing types
Latest filing 2024-08-19 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300653

About Yantai Zhenghai Bio-Tech Co., Ltd.

https://www.zhbio.com

Yantai Zhenghai Bio-Tech Co., Ltd. specializes in the research, development, production, and sale of regenerative medicine materials. The company focuses on tissue engineering and biomaterials to provide solutions for clinical repair and functional reconstruction. Its core product portfolio includes the Heal-All oral repair membrane, absorbable hard cerebral (spinal) membrane patches, and skin repair membranes. These products are widely utilized in stomatology, neurosurgery, and orthopedics. The company leverages advanced processing technologies to ensure biocompatibility and safety in its medical devices. By integrating research with clinical needs, it develops innovative bone repair materials and other biological scaffolds designed to facilitate natural tissue regeneration.

Recent filings

Filing Released Lang Actions
关于公司申报医疗器械注册获得受理的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (941 characters) about the acceptance of a medical device registration application by a regulatory authority (Shandong Provincial Drug Administration). It provides basic product information, current approval stage, and potential impact on the company. There are no financial statements, detailed financial data, or comprehensive report content. The document is an official announcement regarding regulatory approval progress, not a financial report or detailed filing. It fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit other specific categories.
2024-08-19 Chinese
2024年半年度报告摘要
Interim / Quarterly Report Classification · 100% confidence The document is titled as a "2024 年半年度报告摘要" which translates to "2024 Semi-Annual Report Summary." It contains detailed financial data for the half-year period, including revenue, net profit, earnings per share, and asset information. It also discusses business operations, product development, market activities, and management initiatives during the reporting period. The length of the document (5703 characters) and the presence of substantive financial data and analysis confirm it is a comprehensive interim report rather than a brief announcement or summary. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-05 Chinese
2024年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '烟台正海生物科技股份有限公司2024 年半年度报告全文' which translates to 'Yantai Zhenghai Bio-Tech Co., Ltd. 2024 Semi-Annual Report Full Text'. It explicitly states it is a half-year report covering the period from January 1, 2024 to June 30, 2024. The content includes detailed financial data, management discussion and analysis, business overview, risk factors, product information, and other comprehensive financial and operational information typical of an interim or quarterly report. The document length is about 15,000 characters, indicating it is a full report rather than a brief announcement. There is no indication that this is merely an announcement of a report or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-05 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a Supervisory Board resolution announcement regarding the approval of the company's 2024 semi-annual report and its summary. It states that the Supervisory Board has reviewed and approved the procedures and content of the semi-annual report, confirming its accuracy and compliance with regulations. The document does not contain the actual semi-annual report or detailed financial data but rather announces the resolution and approval of the report. It also references that the full semi-annual report and summary are disclosed on the official regulatory website. The document length is short (904 characters) and serves as an announcement of the Supervisory Board's resolution rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS) as a formal announcement related to regulatory compliance and disclosure, not the report itself (which would be classified as an Interim/Quarterly Report (IR)).
2024-08-05 Chinese
上市公司2024年半年度非经营性资金占用及其他关联资金往来情况汇总表
Interim / Quarterly Report Classification · 95% confidence The document is a detailed tabular summary of non-operating fund occupation and other related party fund transactions for the half-year period of 2024. It includes financial data such as beginning balances, cumulative amounts, interest, repayments, and ending balances for related parties. The presence of specific half-year period data and detailed financial figures indicates this is a financial report for a period shorter than a full fiscal year. There is no indication that this is an announcement or a certification; it contains substantive financial data. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-05 Chinese
董事会决议公告
Regulatory Filings Classification · 95% confidence The document is titled '董事会决议公告' which translates to 'Board Resolution Announcement'. It details the resolutions passed at the company's fourth board meeting, including approval of the 2024 semi-annual report and its summary. The document states that the full semi-annual report is disclosed on the official regulatory website, indicating this document is an announcement of the board's approval rather than the report itself. The document length is short (848 characters), and it does not contain the actual financial data or the full report content. Therefore, it fits the category of a Regulatory Filing (RNS) as a formal announcement of board resolutions and reference to the report, not the report itself.
2024-08-05 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.